U.S. Retail Distributors Stock News

ASA Gold and Precious Metals (ASA) has moved into focus after reporting full year 2025 results, with revenue of US$3.98 million and net income of US$664.07 million, alongside fresh buying from major shareholder Saba Capital Management. See our latest analysis for ASA Gold and Precious Metals. The latest results and Saba Capital's recent buying arrive after a sharp pullback, with a 1 day share price return of 10.4% decline and a 7 day return of 12.32% decline. However, the stock has shown...

Watts Water Technologies (WTS) is back on many investors’ radar after recent share price moves, with the stock showing a 0.6% gain over the past day and 8.4% over the past month. See our latest analysis for Watts Water Technologies. That move comes on top of a 30 day share price return of 8.44% and a 90 day share price return of 9.80%. In addition, the 1 year total shareholder return of 45.90% and 5 year total shareholder return of 149.84% point to momentum that has been building over...

Wondering if Columbia Banking System at around US$29.44 is offering good value right now, or if the easy gains are already behind it? The stock has recorded returns of 1.9% over the last 7 days, 5.3% over the past month, 4.4% year to date, 11.5% over 1 year and 46.4% over 5 years, which may catch the eye of investors thinking about growth potential or changing risk perceptions. Recent coverage of Columbia Banking System has focused on its position in the regional banking sector and how...

In late January 2026, Agilysys reported record third-quarter fiscal 2026 results, with revenue of US$80.39 million and net income of US$9.9 million, while modestly raising its full-year revenue guidance to US$318 million. Beyond the headline numbers, the quarter underscored continued momentum in subscription and recurring revenue and progress on large hospitality projects such as its Marriott property management system deployment. With the company slightly upgrading its revenue outlook,...

Amgen (NasdaqGS:AMGN) is being sued over its decision to withdraw certain discounted drug prices from Sagebrush Health Services, a clinic serving underserved patients in California. The lawsuit claims Amgen’s actions unlawfully restricted access to lower cost medicines for economically challenged communities and may breach state law. Separately, Amgen has ended its collaboration with Kyowa Kirin on rocatinlimab, an investigational treatment for atopic dermatitis. The end of the rocatinlimab...

If you are wondering whether Affirm Holdings at around US$60 a share still makes sense for your portfolio, the key question is how its current price lines up with underlying value. The stock has been volatile recently, with a 15.6% decline over the last 7 days, a 19.0% decline over 30 days, and an 18.5% decline year to date, even though the 3 year return sits at a very large gain and the 1 year return is a 1.3% decline. Recent headlines have focused on Affirm's position in the buy now, pay...

Why Ollie’s recent growth metrics are back in focus Ollie's Bargain Outlet Holdings (OLLI) is drawing fresh attention as investors react to its double-digit annual store growth and steady same-store sales gains. This has raised questions about how the company’s expansion is affecting the current share price. See our latest analysis for Ollie's Bargain Outlet Holdings. At a share price of $110.31, Ollie’s has seen a 2.84% 1 day share price gain. Its 90 day share price return of 8.69% and 1...

Core Scientific (NasdaqGS:CORZ) is shifting its focus from bitcoin mining to high performance computing leasing. The company plans to pursue more HPC colocation contracts starting in 2026. Shareholders recently rejected a proposed merger with CoreWeave, keeping Core Scientific independent. Core Scientific, trading at $17.99, is repositioning itself around HPC leasing while still carrying the legacy of its bitcoin mining roots. The stock has returned 23.6% over the past 30 days and 46.6%...

In January 2026, Novavax announced a non-exclusive, worldwide license and option agreement granting Pfizer access to its Matrix-M adjuvant technology for vaccine development in up to two infectious disease areas, including an initial field already chosen and a US$30 million upfront payment this quarter. Together with FDA Breakthrough Therapy Designation for a gastrointestinal stromal tumor regimen combining Pfizer’s Sutent with bezuclastinib, these moves highlight Pfizer’s effort to deepen...

Applied Optoelectronics (AAOI) has been in focus after securing a significant 800G transceiver order from a major hyperscale customer, along with positive commentary on its AI-focused laser products and the launch of a new high-powered pump laser. See our latest analysis for Applied Optoelectronics. Those AI centric product wins sit against a backdrop of sharp moves in the shares, with a 22.09% 7 day share price return and a 25.10% 30 day share price return. At the same time, the 1 year total...

TJX Companies (TJX) has just come off a seven day losing streak, with the stock declining 6.1% as retail sector headwinds and worries about a rich valuation weigh on recent trading. See our latest analysis for TJX Companies. Zooming out, TJX Companies has a 90 day share price return of 6.9% and a 1 year total shareholder return of 21.5%. Recent weakness therefore looks more like cooling momentum after a strong multi year run rather than a sharp change in how the market views its risk or...

What Buckle’s Recent Performance Tells Current Shareholders Buckle (BKE) has drawn attention after a period where the share price shows an 11.5% decline over the past month and a 13.7% decline over the past 3 months, despite positive one year and multi year total returns. See our latest analysis for Buckle. At the current share price of $47.30, Buckle’s recent 7 day and 3 month share price declines sit against a stronger backdrop, with 1 year and 5 year total shareholder returns in...

Crocs recently launched “Wonderfully Unordinary,” its first global omnichannel brand campaign since 2017, supported by a 90-second hero film and an extended roll-out through 2026 and beyond, while also unveiling a remodeled flagship store on New York City’s 34th Street. This marks a shift in Crocs’ branding toward themes of self‑expression and “becoming,” as it seeks a deeper connection with younger consumers through immersive retail and marketing experiences. With this renewed brand...

D.R. Horton (NYSE:DHI) is using aggressive mortgage incentives and rate buydowns to support homebuyer demand in a challenging housing market. The company is combining these incentives with tight cost control as it reports a year over year revenue decline. Despite lower overall revenues, D.R. Horton reports growth in regional sales and resilient net sales orders, pointing to share gains in select markets. D.R. Horton, one of the largest U.S. homebuilders, is leaning on mortgage incentives...

Event context and recent share performance Apollo Commercial Real Estate Finance (ARI) has drawn fresh attention after recent share price moves, with the stock showing a 1 day return of around a 1% decline and a 7 day gain of about 9%. Over the past month the stock has returned roughly 12%, while the past 3 months show a gain of about 10%. This has put recent trading action into focus for investors tracking listed commercial real estate lenders. See our latest analysis for Apollo Commercial...

In recent days, Apellis Pharmaceuticals reported strong momentum for its complement inhibitor Empaveli, including preliminary Q4 2025 U.S. net product revenue of about US$35.00 million, reflecting year-over-year growth and rapid uptake in treating paroxysmal nocturnal hemoglobinuria and other rare conditions with high unmet medical needs. Investor attention has also been drawn to analyst commentary highlighting Empaveli’s early market penetration and underappreciated commercial potential...

Netflix has submitted an amended all cash bid to acquire Warner Bros. Discovery, shifting the structure of the proposed deal. The revised offer would increase Netflix's financial leverage and is drawing closer attention from regulators focused on competition in streaming and filmed entertainment. The move comes as investors assess how a larger content library and studio footprint might weigh against added debt and integration risks. Netflix, NasdaqGS:NFLX, is approaching this bid with its...

In late January 2026, Interparfums, Inc. announced long-term, exclusive worldwide fragrance licenses for the Nautica and David Beckham brands, alongside a multi-decade extension of its GUESS fragrance agreement and reported 2025 net sales of US$1.49 billion. By locking in these licensing partnerships for up to 20 years and projecting tens of millions of dollars in annual Nautica and Beckham fragrance sales, Interparfums is deepening its pipeline of branded fragrance revenues well into the...

Astrana Health recently came under pressure after the Centers for Medicare & Medicaid Services proposed only modest payment updates for Medicare Advantage in 2027, raising questions about future revenue tied to these plans. Analysts highlight that Astrana Health’s encounter-driven, risk-adjustment-focused care model could help limit the impact of these proposed policy changes while the company prepares to report its 2025 results in early March 2026. We’ll now look at how the Medicare...

If you are wondering whether Amphenol at around US$144 per share still offers value after a strong run, you are not alone. The stock has returned 6.6% over the past month, 3.1% year to date, 105.1% over the last year, 262.4% over three years, and 366.0% over five years, which can change how investors think about both its growth potential and its risk. Recent news coverage has focused on Amphenol's role as a major supplier of interconnect solutions across sectors like communications,...

Investor letter spotlight and what it suggests for Globus Medical (GMED) Meridian Growth Fund recently called out Globus Medical (GMED) as a key contributor in its fourth quarter 2025 investor letter, tying the stock’s outperformance to what it described as improving trends in the company’s core operations. The fund pointed to a reacceleration in Globus Medical’s spine business to double digit growth, renewed market share gains, and integration progress from prior acquisitions that it said is...

Textron Inc. has reported past fourth-quarter 2025 results with revenue rising to about US$4.18 billion and net income to US$235 million, alongside issuing 2026 guidance for approximately US$15.50 billion in revenue and GAAP EPS of US$5.39 to US$5.59 from continuing operations. The company also completed a multi-year share repurchase program totaling almost US$2.44 billion and is accelerating investment in its Bell MV-75 program while securing contracts such as a US$163.40 million Mobile...

Fresh analyst upgrades and a higher earnings consensus have pushed Fluence Energy (FLNC) into focus, as improving sentiment on Wall Street appears to be drawing more attention to the energy storage stock. See our latest analysis for Fluence Energy. The stock’s recent run has been strong, with a 55.56% 30 day share price return and a 136.51% 1 year total shareholder return. This suggests momentum has been building as earnings expectations improve and analyst sentiment turns more positive. If...

Uber Technologies (UBER) has put autonomous vehicles at the center of its recent story by launching AV Labs, investing in Waabi, and teaming up with Mercedes Benz and Nvidia on global robotaxi deployment. See our latest analysis for Uber Technologies. Those robotaxi announcements come after a choppy few months for the share price, with a 90 day share price return of a 17.05% decline, a 1 year total shareholder return of 19.75%, and a 3 year total shareholder return of about 14x. This suggests...